Nuclear factor-κB: Fine-tuning a central integrator of diverse biologic stimuli

International Reviews of Immunology

Volumn 27, Issue 5, 2008, Pages 286-292

  Krakauer, Teresa ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Inflammation; Nuclear factor kappa B; Signal pathways; Therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; AUTOREGULATION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; MICROARRAY ANALYSIS; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; THROMBOSIS; TRANSCRIPTION REGULATION; TUMOR IMMUNITY; WOUND HEALING IMPAIRMENT; ANIMAL; ANTIBODY SPECIFICITY; CHEMICAL STRUCTURE; DRUG DESIGN; FEEDBACK SYSTEM; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG DESIGN; FEEDBACK, BIOCHEMICAL; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MODELS, MOLECULAR; NF-KAPPA B; ORGAN SPECIFICITY; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 53949106937     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180802317957     Document Type: Review

References (21)

1. A. Hoffmann and D. Baltimore, Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171-186, 2006.
2. M.S. Hayden and S. Ghosh, Signaling to NF-κB. Genes Dev 18: 2195-2224, 2004.
3. A.S. Baldwin Jr., The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
4. L.A. O'Neill, How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18: 3-9, 2006.
5. B. Beutler, Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430: 257-263, 2004.
6. A. Hoffmann, A. Levchenko, M.L. Scott, and D. Baltimore, The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298: 1241-1245, 2002.
7. M. Karin and Y. Ben-Neriah, Phosphorylation meets ubiquitination: the control of NF-kappa B activity. Ann Rev Immunol 18: 621-663, 2000.
8. J. DiDonato, F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin, Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 16: 1295-304, 1996.
9. A. Hoffmann, T.H. Leung, and D. Baltimore, Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J 22: 5530-5539, 2003.
10. S. Ghosh, M.J. May, and E.B. Kopp, NF-κB/ and Rel roteins:evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
11. M. Karin, Y. Yamamoto, and Q.M. Wang, The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3: 17-26, 2004.
12. G. Gloire, E. Dejardin, and J. Piette, NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
13. G.Y. Park, X. Wang, N. Hu, T.V. Pedchenko, T.S. Blackwell, and J.W. Christman, NIK is involved in nucleosomal regulation by enhancing histone H3 phosphorylation by IKKα. J Biol Chem281: 18684-18690, 2006.
14. P.P. Tak and G. S. Firestein. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-12, 2001.
15. S. Saccani, S. Pantano, and G. Natoli, Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193: 1351-1359, 2001.
16. G. Natoli, S. Saccani, D. Bosissio, and I. Marazzi, Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439-445, 2005.
17. B. Tian, D.E. Nowalk, and A.R. Brasier, A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics 6:137-155, 2005.
18. K.Y. Lee, K. Ito, R. Hayashi, E.P.I. Jazrawi, P.J. Barnes, and I.M. Adcock, NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J Immunol 176: 603-615, 2006.
19. S.C. Sun, P.A. Ganchi, D.W. Ballard, and W.C. Greene, NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway, Science 259: 1912-1915, 1993.
20. D. Chauhan, T. Hideshima, and K.C. Anderson, Targeting proteasomes as therapy in multiple myeloma. Adv Exp Med Biol 615: 251-60, 2008.
21. A.A. Beg, W.C. Sha, R.T. Bronson S, Ghosh, and D. Baltimore, Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170, 1995.